VESTAL, N.Y. — The Binghamton University School of Pharmacy and Pharmaceutical Sciences has signed an articulation agreement with Elmira College.
The pact will allow students to transfer into Binghamton’s doctor of pharmacy (PharmD) program after three years of undergraduate study, Binghamton University announced.
It’s a 3+4 program that will allow qualified Elmira students to complete their bachelor’s degree in biochemistry through coursework taken in their first professional year at Binghamton.
“We’re thrilled with this agreement with Elmira College that creates a smooth path for Elmira students to transition to our school,” Gloria Meredith, founding dean of the School of Pharmacy and Pharmaceutical Sciences, said in a statement. “These are highly qualified students who will build a partnership with Elmira College, and will join with other students from around the state and beyond to become pharmacy professionals offering patient-centered care.”
Students must earn a minimum composite score of 50 on the Pharmacy College Admissions Test (PCAT) taken on or before the January test date. The PCAT will be waived for students who achieve a GPA of 3.1 or higher.
“This partnership with Binghamton University provides our biochemistry students another excellent option for pursuing a career in pharmacy,” said Lynn Gillie, Elmira College pre-health professions advisor and professor of biology. “Students planning to graduate early from Elmira may advance directly into the pharmacy-degree program at Binghamton, providing Elmira students a seamless transition to the next stage of their professional careers.”
Binghamton’s School of Pharmacy also has 3+4 agreements with the Cornell University College of Agriculture and Life Sciences, Wells College, and Ithaca College, as well as 2+4 programs with SUNY Broome Community College, Onondaga Community College, and SUNY Nassau Community College.
Contact Reinhardt at ereinhardt@cnybj.com
P